ANPEP and acute myeloid leukemia: CAR-T cells bispecifically targeting CD13 and TIM3, which are upregulated in LSCs, eliminated patient-derived AML while reducing the cytotoxicity of stem cells and peripheral myeloid cells in mouse models.